Which stocks are experiencing notable movement on Friday?
By Mill Chart
Last update: Mar 15, 2024
Which stocks are experiencing notable movement on Friday?
Today's top gainers
| Ticker | Change | Comment |
|---|---|---|
| VERB | 255.0% | VERB TECHNOLOGY CO INC's (NASDAQ:VERB) shares rose 255.0% to $0.5 during Friday's session. Shareholders saw the stock price going 88.64% lower is the past 6 months. |
| GERN | 91.71% | Positive market sentiment drove GERON CORP's (NASDAQ:GERN) stock price up by 91.71% to $3.35 during Friday's session. A press release (Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS) was released yesterday. |
| CDLX | 71.79% | CARDLYTICS INC (NASDAQ:CDLX) witnessed a notable 71.79% uptick in its shares, reaching $14.07 during Friday's session. Yesterday the company had a press release: Cardlytics Announces Fourth Quarter and Full Year 2023 Financial Results. |
| JTAI | 59.09% | JET.AI INC's (NASDAQ:JTAI) stock price displayed strong growth, advancing 59.09% and reaching $1.05 during Friday's session. In the last 3 months the share price dropped with 81.58%. |
| GOEV | 51.94% | With a 51.94% surge, CANOO INC's (NASDAQ:GOEV) stock price reached $1.99 during Friday's session, signaling positive momentum. Shareholders saw the stock price going 60.0% lower in the past month. |
| OTLK | 42.23% | Investors celebrated as OUTLOOK THERAPEUTICS INC (NASDAQ:OTLK) experienced a 42.23% rise in its shares, closing at $8.15 during Friday's session. Shareholders saw the stock price going 1.0K% higher in the past month. |
| PIII | 41.49% | P3 HEALTH PARTNERS INC (NASDAQ:PIII) experienced a significant 41.49% increase, reaching $1.0 during Friday's session. Yesterday the company had a press release: P3 Health Partners to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024. |
| GOEVW | 37.21% | HENNESSY CAPITAL ACQUIS-CW25's (NASDAQ:GOEVW) stock price displayed strong growth, advancing 37.21% and reaching $0.06 during Friday's session. The stock is trading 27.68% lower than a month ago. |
| VERI | 36.63% | VERITONE INC's (NASDAQ:VERI) shares rose 36.63% to $3.73. In the last 3 months the stock gained 34.48%. |
| LSF | 33.05% | LAIRD SUPERFOOD INC's (NYSEARCA:LSF) stock price is advancing with 33.05% to a price of $3.18. In the last month the stock gained 188.0%. |
Our top gainers page will show you the full list.
Top losers
| Ticker | Change | Comment |
|---|---|---|
| LIAN | -93.18% | LIANBIO-ADR's (NASDAQ:LIAN) stock price encountered a 93.18% decline, reaching $0.34 during Friday's session. The stock is trading 212.0% higher than 6 months ago. |
| CISS | -63.92% | C3IS INC's (NASDAQ:CISS) shares fell 63.92% to $0.03. In the last month the stock lost 33.89%. |
| IMRX | -31.36% | There was a downturn in IMMUNEERING CORP - CLASS A's (NASDAQ:IMRX) shares, as they experienced a 31.36% decline, closing at $1.99 during Friday's session. Two days ago the company had a press release: Immuneering Announces Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors. |
| SLS | -29.03% | The market experienced a downward movement in SELLAS LIFE SCIENCES GROUP I's (NASDAQ:SLS) stock price, closing at $1.1 with a 29.03% decrease during Friday's session. In the last month the stock gained 119.0%. |
| GRPN | -28.89% | The market experienced a downward movement in GROUPON INC's (NASDAQ:GRPN) stock price, closing at $12.92 with a 28.89% decrease during Friday's session. yesterday the company released their earnings. Shareholders saw the stock price going 59.25% higher in the past 3 months. |
| LSDI | -24.7% | LUCY SCIENTIFIC DISCOVERY IN's (NASDAQ:LSDI) stock price is declining with 24.7% to a price of $1.25. Shareholders saw the stock price going 29.0% lower in the past month. |
| AMPS | -24.58% | The market experienced a 24.58% downturn in ALTUS POWER INC's (NYSE:AMPS) stock price, closing at $4.48 during Friday's session. A press release (Altus Power, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results) was released yesterday. |
| DOUG | -19.3% | DOUGLAS ELLIMAN INC's (NYSE:DOUG) shares fell 19.3% to $1.59 during Friday's session. The stock is trading 23.35% lower than 3 months ago. |
| BW | -18.75% | BABCOCK & WILCOX ENTERPR's (NYSE:BW) shares fell 18.75% to $1.04 during Friday's session. Yesterday the company had a press release: Babcock & Wilcox Enterprises Reports Fourth Quarter and Full Year 2023 Results. |
| MNTK | -18.47% | The market experienced a 18.47% downturn in MONTAUK RENEWABLES INC's (NASDAQ:MNTK) stock price, closing at $4.15 during Friday's session. A press release (Montauk Renewables Announces Full Year 2023 Results) was released yesterday. |
For the full top loser list go to our top losers page.
OUTLOOK THERAPEUTICS INC
NASDAQ:OTLK (4/26/2024, 7:08:27 PM)
After market: 8.31 -0.12 (-1.42%)8.43
+0.24 (+2.93%)
OTLK News
ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first...
13 days ago - InvestorPlaceBiotech on a Budget: 7 Stocks Under $10 With Huge PotentialWith the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.
Positive opinion serves as a basis for final decision for potential authorization from the European Commission (EC), expected within 67 days ISELIN, N.J.,...
ISELIN, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced that it has closed its previously announced private placement, for upfront gross proceeds of approximately $60 million from the issuance and sale of shares of the Company’s common stock and accompanying warrants, before deducting placement agent fees and offering expenses. Outlook Therapeutics has the potential to receive additional gross proceeds of up to $99 million upon the full cash exercise of the warrants issued in the private placement, before deducting placement agent fees and offering expenses.
ISELIN, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”), a biopharmaceutical company working to...
2 months ago - InvestorPlace7 of the Best Speculative Stocks You Can Snag for Less Than $1Although speculative stocks under $1 are by their very nature extremely risky, these ideas might have enough to go the distance.
2 months ago - InvestorPlace7 Biotech Penny Stocks on the Verge of Clinical Trial VictoryBiotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.
2 months ago - Seeking AlphaOutlook Therapeutics stock climbs 13% amid Chardan upgrade (NASDAQ:OTLK)Shares of Outlook Therapeutics (OTLK) climbed 13% after Chardan upgraded the stock to buy, citing the company’s recent private placement and the full cash exerc
NORSE EIGHT underway with first subject dosed and additional clinical sites beginning enrollment Continue to expect planned resubmission of the ONS-5010...
NORSE EIGHT clinical trial is being conducted under Special Protocol Assessment (SPA) from FDA to support expected resubmission of the ONS-5010 Biologics...
